Charles Schwab
EDVA

Charles Schwab’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Charles Schwab’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-127
Closed -$9.37K – 3674
2024
Q1 		$9.37K Hold
127
– – ﹤0.01% 3463
2023
Q4 		$11.2K Hold
127
– – ﹤0.01% 3520
2023
Q3 		$12K Hold
127
– – ﹤0.01% 3553
2023
Q2 		$22.8K Hold
127
– – ﹤0.01% 3543
2023
Q1 		$33.4K Buy
+127
New +$25.2K ﹤0.01% 3430

Other funds holding EDVA

CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SCTC
Sanibel Captiva Trust Company Sanibel, Florida $4.02B AUM 34.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab's EDVA Position: Q2 2024 in Review

Charles Schwab sold out of Endovia Health Sciences, Inc. (EDVA) in Q2 2024, closing a stake of 127 shares — an estimated $9.37K sold.

Charles Schwab first reported a position in EDVA in Q1 2023 and held it in 5 quarters. The position peaked at $33.4K in Q1 2023. 31 funds tracked by Wall St. Rank hold EDVA as of Q2 2024.

  • Charles Schwab reported no remaining Endovia Health Sciences, Inc. position as of Q2 2024 after selling out during the quarter.
  • Charles Schwab sold 127 Endovia Health Sciences, Inc. shares in Q2 2024, an estimated $9.37K.
  • Charles Schwab first reported a position in Endovia Health Sciences, Inc. in Q1 2023 and held it in 5 quarters.
  • Charles Schwab's Endovia Health Sciences, Inc. position peaked at $33.4K in Q1 2023.
  • 31 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2024.

Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.